- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Inhibition and degradation of NRAS with a pan-NRAS monobody ; volume:43 ; number:48 ; day:8 ; month:10 ; year:2024 ; pages:3489-3497 ; date:11.2024
Oncogene ; 43, Heft 48 (8.10.2024), 3489-3497, 11.2024
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Whaby, Michael
Ketavarapu, Gayatri
Koide, Akiko
Mazzei, Megan
Mintoo, Mubashir
Glasser, Eliezra
Patel, Unnatiben
Nasarre, Cecile
Sale, Matthew J.
McCormick, Frank
Koide, Shohei
O’Bryan, John P.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41388-024-03186-y
- URN
-
urn:nbn:de:101:1-2502082200550.666592530234
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Whaby, Michael
- Ketavarapu, Gayatri
- Koide, Akiko
- Mazzei, Megan
- Mintoo, Mubashir
- Glasser, Eliezra
- Patel, Unnatiben
- Nasarre, Cecile
- Sale, Matthew J.
- McCormick, Frank
- Koide, Shohei
- O’Bryan, John P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Induction of N-Ras degradation by flunarizine-mediated autophagy
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
NRAS destines tumor cells to the lungs
MEK targeting in N-RAS mutated metastatic melanoma
NRAS und SMAD4 als Biomarker bei fortgeschrittenem Pankreaskarzinom
STAT3 – the switch of melanoma-associated NRAS mutations
Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG
Die Rolle onkogener NRAS-Mutationen in der kolorektalen Tumorgenese
Targeting retinoid receptors with dysregulated microNRAs in pancreatic duct adenocarcinoma
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma
Missense mutation of NRAS is associated with malignant progression in neurocutaneous melanosis
Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor
Induction of N-Ras degradation by flunarizine-mediated autophagy
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
NRAS destines tumor cells to the lungs
MEK targeting in N-RAS mutated metastatic melanoma
NRAS und SMAD4 als Biomarker bei fortgeschrittenem Pankreaskarzinom
STAT3 – the switch of melanoma-associated NRAS mutations
Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG
Die Rolle onkogener NRAS-Mutationen in der kolorektalen Tumorgenese
Targeting retinoid receptors with dysregulated microNRAs in pancreatic duct adenocarcinoma
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma
Missense mutation of NRAS is associated with malignant progression in neurocutaneous melanosis
Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor
Induction of N-Ras degradation by flunarizine-mediated autophagy
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
NRAS destines tumor cells to the lungs
MEK targeting in N-RAS mutated metastatic melanoma
NRAS und SMAD4 als Biomarker bei fortgeschrittenem Pankreaskarzinom
STAT3 – the switch of melanoma-associated NRAS mutations
Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG
Die Rolle onkogener NRAS-Mutationen in der kolorektalen Tumorgenese
Targeting retinoid receptors with dysregulated microNRAs in pancreatic duct adenocarcinoma
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma
Missense mutation of NRAS is associated with malignant progression in neurocutaneous melanosis